AMD
High-dose Aflibercept Pushes Dosing Interval to Five Months
Nearly half of subjects went 20 weeks or longer between injections with the 8mg formulation. The regimen also maintained BCVA gains out to 96 weeks.
05/13/2024
PED Lesions, Hyperreflective Foci Associated With Visual Decline in Dry AMD
Mesopic dysfunction was found following previous predominant rod-mediated function loss, whereas the overall highest functional loss was detected with development of cRORA lesions.
05/03/2024
Meta-analysis Associates Three Air Pollutants with AMD Risk
The relationship was not causal, suggesting that more research is needed to elucidate the underlying mechanisms.
05/03/2024
Study: Blue-Light IOLs Can Reduce Progression of Macular Atrophy, But Not Incidence
Following cataract surgery, the pathology developed in 23% of eyes with filtering lens implants and 19% without. Mean annual increases, however, were 0.78mm2 and 1.26mm2, respectively.
05/02/2024
Ganglion Cell Complex Thickness Reduced in AMD
The most significant inner retinal alterations were observed in those with late-stage disease and/or GA, while little difference was noted between early and intermediate macular degeneration.
05/01/2024
Three Home-monitoring Vision Tests for nAMD Fall Short in Diagnostic Accuracy
The options called KeepSight, MyVisionTrack and MultiBit are not yet ready for implementation in clinical practice, researchers say.
04/30/2024
AREDS Report Updates Simplified Severity Scale
This revision—accounting for reticular pseudodrusen and GA—shows that progression rates are substantially higher when using a more comprehensive approach.
04/25/2024
Heavy Smoking, High BMI Associated With Earlier Onset nAMD
Study also finds intraretinal fluid results in a fast-progressing disease, and these patients tend to be older at the time of diagnosis and remain on treatment for a shorter time.
04/15/2024
Similarities and Differences Between Pachychoroid GA and Conventional GA Identified
Understanding these features may help disease diagnosis in Asian populations. Patients with the former subtype were significantly younger, predominantly male and had a slower progression rate.
04/12/2024
Study Finds Imaging Biomarkers Associated with GA Growth Rate
Progression is positively associated with non-exudative subretinal fluid and hyperreflective material as well as iRORA. It’s negatively associated with retinal pseudocysts and subfoveal choroid thickness.
04/01/2024
Upcoming Events
June 4, 2024
Rethinking Dry Eye Disease: A Contemporary Approach to a Complex Condition
Location: Virtual
Presenters: Karl G. Stonecipher, MD, and Jessica Steen, OD
Webinar: 8:00pm ET
Sponsored by Bausch + Lomb
June 19, 2024
Showcasing Inflammation and IOP Control
Location: The Palm Nashville, TN
Presenters: Nora Lee Cothran, OD, and Walter Whitley, OD, MBA
Time: 6:15pm CT
Sponsored by Bausch + Lomb
September 8, 2024
Ocular Surface Symposium
Location: Renaissance Chicago Downtown Hotel
Presenter: Paul Karpecki, OD
